Looking for people at high cardiovascular risk? Look at serum-creatinine

European Heart Journal

Volumn 24, Issue 5, 2003, Pages 381-383

  Manna, J F E ^a   Dulau Florea, I ^b   Franke, J ^b  

^a Klinikum Schwabing   (Germany)

^b Ger Inst High Blood Pressure Res   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFECT; EDITORIAL; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART PROTECTION; HIGH RISK POPULATION; HUMAN; KIDNEY FAILURE; PREDICTION; PRIORITY JOURNAL;

CREATININE; GLOMERULAR FILTRATION RATE; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 0037334951     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-668X(02)00699-1     Document Type: Editorial

References (15)

1. Hillege HL, van Gilst WH, van Veldhuisen DJ et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J 2003;24:412-20.
2. Al Suwaidi J, Reddan DN, Williams K et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002;106:974-80.
3. Mann JFE, Gerstein HC, Pogue J, Lonn E, Yusuf S. Cardiovascular risk in patients with early renal insufficiency. Am J Cardiovasc Drugs 2002;2:157-62.
4. McCullough PA, Soman SS, Sah SS et al. Risk associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardial 2000;36:679-84.
5. Mann JFE, Gerstein HC, Pogue J et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Int Med 2001; 134:629-36.
6. Hillege HL, Girbes AR, de Kam PF et al. Renal function, neurohormonal activation and survival in patients with chronic heart failure. Circulation 2000;102:203-10.
7. Shulman NB, Ford CE, Hall WD et al. Prognostic value of serum creatinine and the effect of treatment of hypertension on renal function: HDFP results. Hypertension 1989; 13(Suppl 1):1-80-93.
8. Ruilope LM, Salvetti A, Jamerson K et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001;12:218-25.
9. Culleton BF, Larson MG, Wilson PWF et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999;56:2214-9.
10. Kasiske B. The kidney in cardiovascular disease. Ann Int Med 2001;134:707-9.
11. Manhunt et al. J Am Soc Nephrol 2001;12:225A.
12. Parfrey PS, Foley RN The clinical epidemiology of cardiac disease in chronic uremia. J Am Soc Nephrol 1999; 10:1053-8.
13. Maschio G, Alberti D, Janin G et at. Effects of the ACE inhibitor benezepril on the progression of chronic renal insufficiency. N Engl J Med 1996;334:939-45.
14. Bakris GL, Weir MR. Inhibitor-associated elevations in serum creatinine: is this a cause for concern? Arch Int Med 2000; 160:685-93.
15. Hilgers KF, Veelken R, Schmieder RE et al. ACE inhibitors versus AT1 receptor antagonists in patients with chronic renal disease. J Am Soc Nephrol 2002;13:1100-8.